The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex

Area of Science:

• Neuropharmacology
• Biochemistry

Background:

• Angiotensin converting enzyme (ACE) plays a role in various physiological processes.
• Understanding the distribution and characteristics of ACE in the brain is crucial for neurological drug development.

Purpose of the Study:

• To identify and characterize the angiotensin converting enzyme (ACE) inhibitor binding site in the human temporal cortex.
• To determine if the radioligand [3H]SQ29,852 selectively labels the ACE inhibitor recognition site.

Main Methods:

• Radioligand binding assay using [3H]SQ29,852 in human temporal cortex homogenates.
• Competition binding studies with various ACE inhibitors and thiorphan.

Main Results:

• A single high-affinity ACE inhibitor recognition site was identified in the human temporal cortex.
• The rank order of affinity for competing ligands matched their known potency in inhibiting brain ACE activity.
• [3H]SQ29,852 demonstrated selective binding to the ACE inhibitor site.

Conclusions:

• The radioligand [3H]SQ29,852 selectively labels the inhibitor recognition site of ACE in the human temporal cortex.
• This provides a valuable tool for studying ACE in the human brain.
• Findings support the potential for developing brain-penetrant ACE inhibitors for neurological conditions.